Zyn nicotine pouches: America's new addictive obsession

Sales of Zyn nicotine pouches are soaring in the US, prompting Philip Morris International to boost production to meet demand. The pouches are placed between the gum and lip, releasing nicotine over time, and are discreet, producing no smoke or odors. Nicotine pouches are becoming a new addictive habit in America, with people using them in various settings, including at games, movies, and workplaces. Celebrity Josh Brolin has even admitted to using them while sleeping, although this is not recommended. The product is addictive due to the presence of nicotine, but it does not cause cancer as it does not contain tobacco. Advocates argue that nicotine pouches can serve as a safer alternative to smoking, with Philip Morris International US CEO Stacey Kennedy stating that nicotine has cognitive benefits. However, tobacco industry watchdogs warn that products containing nicotine can serve as a gateway to smoking, especially for teens. US shipments of Zyn pouches have risen significantly, with the company generating 42% of its revenue from smoke-free products in the first quarter of 2025. The FDA has authorized the marketing of 20 Zyn products, citing scientific data that shows they can benefit adults who switch from cigarettes and smokeless tobacco products. As the use of nicotine pouches continues to grow, concerns remain about their potential impact on public health, particularly among adolescents and other new users of nicotine.